Literature DB >> 3036965

A comparative study of herpes simplex infections in renal transplant and leukemic patients.

M S Greenberg, H Friedman, S G Cohen, S H Oh, L Laster, S Starr.   

Abstract

Herpes simplex virus (HSV) reactivation and lesion formation were studied in 68 renal transplant recipients and 30 leukemic patients. Antibody titers to HSV were determined, and seropositive patients were examined three times weekly for up to one month. Surveillance cultures were taken for oral HSV, and HSV culture and cytology were done for all oral lesions found. In a smaller number of patients, immune responses were determined. HSV reactivation was similar in the transplant and leukemic groups (46.8% vs. 50%), but a significant difference in the incidence of HSV lesion formation was noted between the two groups. Of the transplant patients in whom HSV reactivated, 31.8% developed HSV lesions; of leukemic patients in whom HSV reactivated, 100% developed HSV lesions. Differences in the incidence of formation of HSV lesions in these groups of immunosuppressed patients suggest that reactivation of HSV and formation of HSV lesions may involve different mechanisms. Low levels of antibody-dependent cellular cytotoxicity were noted in leukemic patients and may contribute to increased formation of HSV lesions in this group.

Entities:  

Mesh:

Year:  1987        PMID: 3036965     DOI: 10.1093/infdis/156.2.280

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  16 in total

1.  Herpes simplex keratitis in renal transplant patients.

Authors:  I Kremer; A Wagner; D Shmuel; A Yussim; Z Shapira
Journal:  Br J Ophthalmol       Date:  1991-02       Impact factor: 4.638

2.  Comparison of Posttransplant Dermatologic Diseases by Race.

Authors:  Christina Lee Chung; Kumar S Nadhan; Christine M Shaver; Lauren M Ogrich; Mark Abdelmalek; Carrie Ann Cusack; Gregory E Malat; Ellen N Pritchett; Alden Doyle
Journal:  JAMA Dermatol       Date:  2017-06-01       Impact factor: 10.282

3.  Neutralizing antibodies inhibit axonal spread of herpes simplex virus type 1 to epidermal cells in vitro.

Authors:  Z Mikloska; P P Sanna; A L Cunningham
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

Review 4.  Assessing and restoring adaptive immunity to HSV, VZV, and HHV-6 in solid organ and hematopoietic cell transplant recipients.

Authors:  Madeleine R Heldman; Kaja M Aagaard; Joshua A Hill
Journal:  Clin Microbiol Infect       Date:  2022-02-10       Impact factor: 13.310

5.  2-[4,5-Difluoro-2-(2-fluorobenzoylamino)-benzoylamino]benzoic acid, an antiviral compound with activity against acyclovir-resistant isolates of herpes simplex virus types 1 and 2.

Authors:  Mårten Strand; Koushikul Islam; Karin Edlund; Christopher T Oberg; Annika Allard; Tomas Bergström; Ya-Fang Mei; Mikael Elofsson; Göran Wadell
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

6.  Recombinant human Fab to glycoprotein D neutralizes infectivity and prevents cell-to-cell transmission of herpes simplex viruses 1 and 2 in vitro.

Authors:  R Burioni; R A Williamson; P P Sanna; F E Bloom; D R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

7.  Herpes simplex virus and oral mucositis in children with cancer.

Authors:  G Carrega; E Castagnola; A Canessa; P Argenta; R Haupt; G Dini; A Garaventa
Journal:  Support Care Cancer       Date:  1994-07       Impact factor: 3.603

8.  Herpes simplex virus and intraoral ulcers in immunocompromised patients with haematologic malignancies.

Authors:  O J Bergmann; S C Mogensen; J Ellegaard
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-03       Impact factor: 3.267

9.  Comparative analysis of salivary zinc level in recurrent herpes labialis.

Authors:  Faezeh Khozeimeh; Nasim Jafari; Ahmad Movahedian Attar; Shahram Jafari; Masoud Ataie
Journal:  Dent Res J (Isfahan)       Date:  2012-01

10.  Antiherpevirus activity of Artemisia arborescens essential oil and inhibition of lateral diffusion in Vero cells.

Authors:  Manuela Saddi; Adriana Sanna; Filippo Cottiglia; Lorenza Chisu; Laura Casu; Leonardo Bonsignore; Alessandro De Logu
Journal:  Ann Clin Microbiol Antimicrob       Date:  2007-09-26       Impact factor: 3.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.